Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Ocular Leishmaniasis: A Case Report Pubmed



Sadeghian G1 ; Nilfroushzadeh MA2, 3 ; Moradi SH4 ; Hanjani SH5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Dermatology, Skin Disease and Leishmaniasis Research Center, Isfahan University of Medical Sciences and Health Services, Isfahan, Iran
  2. 2. Department of Dermatology, Tehran University, Isfahan, Iran
  3. 3. Skin Disease and Leishmaniasis Research Center, Isfahan, Iran
  4. 4. Department of Infectious and Tropical Diseases, Skin Disease and Leishmaniasis Research Center, Isfahan University of Medical Sciences and Health Services, Isfahan, Iran
  5. 5. Isabne Maryam Hospital, Isfahan University of Medical Sciences and Health Services, Isfahan, Iran

Source: Dermatology Online Journal Published:2005


Abstract

Cutaneous leishmaniasis (CL) is a protozoal disease which is endemic in Iran usually caused by Leishmaniasis major and Leishmaniasis tropica and transmitted by the bite of a sandfly. In Isfahan province CL is highly prevalent and we observe some unusual clinical features of disease. The eyelid is rarely involved possibly because the movement of the lids prevents the fly vector from biting the skin in this region. We report a case of ocular leishmaniasis with eyelid and conjunctival involvement that had simulated chalazion and was complicated with trichiasis. The patient was diagnosed by direct smear, culture, and PCR from the lesions. He was treated with systemic sodium stibogluconate (20 mg/kg/day) for 20 days and subsequently surgery for trichiasis. The patient was clinically cured with this treatment, however the disease had left complications, including palpebral and conjanctival scaring, corneal opacity, and eyelash loss. © 2005 Dermatology Online Journal.
Related Docs
View other Related Docs
1. Clinical Picture of Cutaneous Leishmaniasis in Isfahan, Iran, International Journal of Dermatology (1994)
2. Epidemiology and Clinical Features of Cutaneous Leishmaniasis in Badrood City, Iran, in 2013, Journal of Isfahan Medical School (2015)
3. Comparison of Healing Effects of Local Injection of Glucantime With or Without Trichloroacetic Acid 50% in Cutaneous Leshmaniasis, Journal of Isfahan Medical School (2009)
4. Comparing the Effects of Topical Miltefosine and Glucantime in Treatment of Cutaneous Leishmaniasis, Journal of Isfahan Medical School (2014)
5. Cutaneous Leishmaniasis Reinfection: Skin Disease and Leishmaniasis Research Center, Isfahan, Iran, Journal of Isfahan Medical School (2015)
6. Visceral Leishmaniasis in a Patient With Cutaneous Lesions, Negative Leishman-Donovan Bodies and Immunological Test: A Case Report, Journal of Research in Medical Sciences (2011)
7. The Efficacy of Treatment With Intralesional Meglumine Antimoniate Alone, Compared With That of Cryotherapy Combined With the Meglumine Antimoniate or Intralesional Sodium Stibogluconate, in the Treatment of Cutaneous Leishmaniasis, Annals of Tropical Medicine and Parasitology (2003)
8. The Epidemiology of Cutaneous Leishmaniasis in Isfahan Province, Iran, During 2001-2011, Journal of Isfahan Medical School (2015)
Experts (# of related papers)
View all Related Experts
Seyed Hossein Hejazi (38)
Ali Asilian (15)
Other Related Docs
9. Comparison Between the Efficacy of Photodynamic Therapy and Topical Paromomycin in the Treatment of Old World Cutaneous Leishmaniasis: A Placebo-Controlled, Randomized Clinical Trial, Clinical and Experimental Dermatology (2006)
10. Treatment of Recurrent Cutaneous Leishmaniasis, International Journal of Dermatology (1995)
11. Comparison Between the Efficacy of Photodynamic Therapy and Topical Paromomycin in the Treatment of Old World Cutaneous Leishmaniasis: A Placebo-Controlled, Randomized Clinical Trial, Indian Journal of Dermatology (2006)
12. Comparison of Three Different Therapies for Cutaneous Leishmaniasis and Identification of the Etiologic Isolates in Isfahan, Iran, Archives of Iranian Medicine (2020)
13. Effect of Combination Therapy With Systemic Glucantime and Pentoxifylline in the Treatment of Cutaneous Leishmaniasis, International Journal of Dermatology (2006)
14. A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Itraconazole in the Treatment of Cutaneous Leishmaniasis, Journal of the European Academy of Dermatology and Venereology (2005)
15. Molecular Identification of Leishmania Species in Phlebotomus Alexandri (Diptera: Psychodidae) in Western Iran, Journal of Arthropod-Borne Diseases (2020)
16. Comparison Between the Efficacy of Photodynamic Therapy and Topical Paromomycin in the Treatment of Old World Cutaneous Leishmaniasis: A Placebo-Controlled, Randomized Clinical Trial, Journal of Isfahan Medical School (2012)
17. Emergence of Cutaneous Leishmaniasis Due to Leishmania Major in a New Focus of Central Iran, Transactions of the Royal Society of Tropical Medicine and Hygiene (2009)
18. Treatment of Cutaneous Leishmaniasis With Ketoconazole Cream, Journal of Dermatological Treatment (2003)
19. Vaccination in Leishmaniasis: A Review Article, Iranian Biomedical Journal (2022)
20. Demographic and Clinical Characteristics of Children With Cutaneous Leishmaniasis in Isfahan Province, Iran, During 2011-2015, Journal of Isfahan Medical School (2017)
21. Comparative Effect of Topical Trichloroacetic Acid and Intralesional Meglumine Antimoniate in the Treatment of Acute Cutaneous Leishmaniasis, International Journal of Pharmacology (2006)
22. Evaluation of Leishmanin Skin Test Reaction in Different Variants of Cutaneous Leishmaniasis, Indian Journal of Dermatology (2013)
23. The Skin Side Effects of Topical Glucantime in Patients With Cutaneous Leishmaniasis, Journal of Isfahan Medical School (2015)
24. The Efficacy of 5% Trichloroacetic Acid Cream in the Treatment of Cutaneous Leishmaniasis Lesions, Journal of Dermatological Treatment (2012)
25. Detection of Leishmania Parasites From Cutaneous Leishmaniasis Patients With Negative Direct Microscopy Using Nnn and Pcr-Rflp, Journal of Isfahan Medical School (2012)
26. Pcr-Rflp Diagnosis and Characterization of Leishmania Species Causing Human Cutaneous Leishmaniasis and Evaluation of Treatment Times With Glucantime in These Patients, Tropical Biomedicine (2016)
27. Evaluation of the 11-Year Trend of Cutaneous Leishmaniasis in Six Main Foci of the Disease in Isfahan Province During the Years 2008 to 2018, Journal of Isfahan Medical School (2022)
28. Evaluation of the Biodiversity and Distribution of Sand Flies and Tracking of Leishmania Major in Them in Central Iran, International Journal of Environmental Health Research (2024)
29. Efficacy of Integrated Pest Management in Controlling and Preventing Zoonotic Cutaneous Leishmaniasis in Isfahan Province, Iran, Journal of Isfahan Medical School (2012)
30. Topical Effectiveness of Different Concentrations of Nanosilver Solution on Leishmania Major Lesions in Balb/C Mice, Journal of Vector Borne Diseases (2012)
31. Evaluation of Community Interventions in Changes in Incidence of Cutaneous Leishmaniasis in Isfahan Province From 2002 to 2018: An Interrupted Time Series Regression Analysis, Iranian Journal of Epidemiology (2021)
32. Cutaneous Necrosis After the Injection of Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis: A Rare Case Report, Journal of Isfahan Medical School (2019)
33. Treatment of Cutaneous Leishmaniasis: Cassia Fistula Fruit Gel-Intralesional Glucantime Vs. Placebo Gel- Intralesional Glucantime Combination, Tehran University Medical Journal (2010)
34. Serum Monocyte Chemotactic Protein-1 and Nitric Oxide in Cutaneous Leishmaniasis Patients Before and After Treatment With Glucantime, Journal of Isfahan Medical School (2012)
35. Epidemiological Aspects of Cutaneous Leishmaniasis in Iran, Archives of Clinical Infectious Diseases (2015)
36. Comparison of Intralesionally Injected Zinc Sulfate With Meglumine Antimoniate in the Treatment of Acute Cutaneous Leishmaniasis, Dermatology (2004)
37. Therapeutic Effect of Topical Tamoxifen in Murine Cutaneous Leishmaniasis Caused by Leishmania Major, Antimicrobial Agents and Chemotherapy (2024)
38. A Randomised, Double-Blind, Controlled Trial of a Killed L. Major Vaccine Plus Bcg Against Zoonotic Cutaneous Leishmaniasis in Iran, Vaccine (1999)
39. An Outbreak of Cutaneous Leishmaniasis Due to Leishmania Major in an Endemic Focus in Central Iran, Journal of Parasitic Diseases (2022)
40. Comparative Molecular Epidemiology of Leishmania Major and Leishmania Tropica by Pcr-Rflp Technique in Hyper Endemic Cities of Isfahan and Bam, Iran, Case Reports and Clinical Practice Review (2010)
41. Bacterial Superinfection in Zoonotic Cutaneous Leishmaniasis, Medical Science Monitor (2012)
42. Molecular Identification and Phylogenetic Classification of Leishmania Spp. Isolated From Human Cutaneous Leishmaniasis in Iran: A Cross-Sectional Study, Iranian Journal of Parasitology (2018)
43. A Comparison Between the Effects of Glucantime, Topical Trichloroacetic Acid 50% Plus Glucantime, and Fractional Laser Plus Glucantime on Cutaneous Leishmaniasis Lesions, Journal of Isfahan Medical School (2013)
44. The Study of the Inhibitory Effects of Aqueous and Ethanolic Extracts of Ziziphora Tenuior L. on the Proliferation of Leishmania Major Amastigotes, Iranian Journal of Dermatology (2018)
45. Heat Therapy for Cutaneous Leishmaniasis: A Literature Review, Journal of Research in Medical Sciences (2021)
46. Effect of Adjunctive Topical Liposomal Azithromycin on Systemic Azithromycin on Old World Cutaneous Leishmaniasis: A Pilot Clinical Study, Iranian Journal of Pharmaceutical Research (2021)
47. Effect of Topical Honey Application Along With Intralesional Injection of Glucantime in the Treatment of Cutaneous Leishmaniasis, BMC Complementary and Alternative Medicine (2007)
48. Identification of Leishmania Isolates From Healing and Nonhealing Cutaneous Leishmaniasis Patients Using Internal Transcribed Spacer Region Pcr, Jundishapur Journal of Microbiology (2014)
49. Sandfly Fauna in an Endemic Focus for Cutaneous Leishmaniasis in Dezful District, Iran (2018-2019), Journal of Isfahan Medical School (2020)
50. Combination of Continuous Wave Co2 Laser and Topical Application of Trichloroacetic Acid 50% Vs Co2 Laser Alone the Treatment of Cutaneous Leishmaniasis (A Case Series of 6 Patients), Journal of Cosmetic Dermatology (2020)